Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Retinitis pigmentosa
  • Paper Session
  • Share Icon
    Map Icon
    Bookmark Icon
  • 12-Month Safety and Efficacy Evaluation of HORA-PDE6B, a Gene Therapy Targeting Patients with Retinitis Pigmentosa Due to Biallelic PDE6B Gene Mutation.
    • Schedule
    Notes
  • 236
    Set Timezone

Location: 612 - Seattle Convention Center - Arch Building

Presentation Number: 2134

Abstract Author Block: *Jean-Baptiste Ducloyer, Guylene Le Meur, Pierre Lebranchu, Fanny BILLAUD, Lise Giraud, Sandrine Meunier, Nicole Brument, Patricia Françon, catherine MATHIS, Serge Fitoussi, Michel Weber

4045293

Session Types
Section
Main Session
Discussion